![]() Humanigen Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science. | ||
Founding Date | Founding Date 2000 | Founding Date 1842 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Burlingame, US HQ Dublin, IE London, GB Kansas City, US | Locations Guildford, GB HQ São José Dos Campos, BR Sofia, BG Milton, CA Pointe Claire, CA Vaughan, CA Beijing, CN see more |
Employees | Employees 233% decrease | Employees 9465% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $2.5m (FY, 2022) | Revenue (est.) £165.1m (FY, 2025) |
Net income | Net income ($70.7m) (FY, 2022) | Net income £13.9m (FY, 2025) |